The current study concluded that silencing NEAT1 expression could enhance the negative regulation of PEG3 by miR-129-5p and effectively reduce the fibrotic characteristics of HSCs in the setting of NASH involving the NF-κB signaling pathway. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.